Chris Viehbacher, Biogen CEO (Photo by Suzanne Kreiter/The Boston Globe via Getty Images)

Bio­gen’s R&D prun­ing hits dig­i­tal health as biotech scraps 23,000-per­son cog­ni­tive study with Ap­ple

Bio­gen axed its 23,000-per­son cog­ni­tive health study with Ap­ple phones and watch­es last week as part of a broad­er pull­back in the biotech’s fledg­ling dig­i­tal health unit, per an up­date to a US fed­er­al tri­als data­base.

Just two years in­to its dig­i­tal health ex­pan­sion, Bio­gen is cut­ting back, per a STAT News re­port from Wednes­day cit­ing Bio­gen cor­po­rate de­vel­op­ment leader Adam Keeney. The move comes as Bio­gen’s new lead­er­ship con­sol­i­dates its pipeline, re­moves 1,000 po­si­tions and di­gests its first ac­qui­si­tion in four years.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.